Targeting the RNA translatome to enhance anti-mitotic chemotherapy.
Targeting the RNA translatome to enhance anti-mitotic chemotherapy.
批准号:
477272
负责人:
Teodoro Jose G
金额:
$7.29万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-10-01 至 2023-10-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
An important class of cancer therapeutics known as anti-mitotics are front line therapies for several cancers including breast and lung. However, the success of these drugs is limited by their toxicity and the development of drug resistance. The efficacy
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Viral exploitation of Mg transport pathways to facilitate replication.
-
批准号:479564
-
项目类别:Operating Grants
-
资助金额:$78.02万
-
财政年份:2023
-
负责人:Teodoro Jose G
-
依托单位:
Targeting the RNA translatome to enhance anti-mitotic chemotherapy.
-
批准号:478612
-
项目类别:Operating Grants
-
资助金额:$81.64万
-
财政年份:2023
-
负责人:Teodoro Jose G
-
依托单位:
Montreal International DNA Tumour Virus Meeting 2020
-
批准号:412068
-
项目类别:Miscellaneous Programs
-
资助金额:$0.73万
-
财政年份:2019
-
负责人:Teodoro Jose G
-
依托单位:
Role of triglyceride metabolism in colitis and colorectal cancer progression.
-
批准号:387347
-
项目类别:Operating Grants
-
资助金额:$4.37万
-
财政年份:2018
-
负责人:Teodoro Jose G
-
依托单位:
Deregulation of the anaphase promoting complex in human cancer
-
批准号:371758
-
项目类别:Operating Grants
-
资助金额:$73.01万
-
财政年份:2017
-
负责人:Teodoro Jose G
-
依托单位:
Arresten as a biomarker and therapeutic for Pancreatic cancer
-
批准号:341760
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2016
-
负责人:Teodoro Jose G
-
依托单位:
Levels of serum Arresten as a risk factor for the development and progression of high fatality cancers.
-
批准号:363278
-
项目类别:Operating Grants
-
资助金额:$5.46万
-
财政年份:2016
-
负责人:Teodoro Jose G
-
依托单位:
Montreal International DNA Tumour Virus Meeting 2016
-
批准号:325258
-
项目类别:Miscellaneous Programs
-
资助金额:$0.73万
-
财政年份:2015
-
负责人:Teodoro Jose G
-
依托单位:
Tumour suppressor mediated mechanisms of angiogenesis inhibition
-
批准号:224817
-
项目类别:Operating Grants
-
资助金额:$27.52万
-
财政年份:2011
-
负责人:Teodoro Jose G
-
依托单位:
海外基金